Location History:
- Müchen, DE (2012)
- München, DE (2013 - 2015)
- Munich, DE (2012 - 2024)
Company Filing History:
Years Active: 2012-2024
Title: Ute Jäger: Innovator in Therapeutic Antibodies
Introduction
Ute Jäger is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of therapeutic antibodies, holding a total of 6 patents. Her work focuses on developing innovative solutions for treating various medical conditions, particularly hematological malignancies.
Latest Patents
One of her latest patents is titled "Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38." This invention provides novel antibodies and methods for using recombinant antigen-binding regions and antibodies that are specific for CD38. CD38 plays an integral role in various disorders or conditions. The methods take advantage of newly discovered antibodies and their surprising properties, such as the ability to bind CD38 of minipig origin and induce specific killing of cells that express CD38 through cross-linking. These antibodies and the novel methods for using them can be utilized to treat conditions like multiple myeloma.
Career Highlights
Ute Jäger is currently associated with Morphosys AG, a company known for its focus on developing innovative therapies. Her work at Morphosys AG has been instrumental in advancing the field of therapeutic antibodies.
Collaborations
Ute collaborates with Michael Tesar, contributing to the innovative research and development efforts at Morphosys AG.
Conclusion
Ute Jäger's contributions to the field of therapeutic antibodies exemplify her commitment to innovation and improving patient outcomes. Her patents and ongoing work continue to pave the way for advancements in medical treatments.